Amerant Bancorp Inc. 2024 Q2 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. Amerant Bancorp Inc. is a bank holding company headquartered in Coral Gables, Florida, operating primarily through its subsidiary, Amerant Bank, N.A. The Company serves markets in South Florida, Tampa, Houston, and New York, offering deposit, credit, investment, and wealth management services. A significant business development during the period was the agreement to sell its Houston banking operations (six branches) to MidFirst Bank, with regulatory approval received in July 2024 and a closing expected in November 2024.
Key Financial Metrics
| Metric | Q2 2024 (Three Months) | Q2 2023 (Three Months) | YTD 2024 (Six Months) | YTD 2023 (Six Months) |
|---|---|---|---|---|
| Net Income (Attributable to Amerant) | $4.96 million | $7.31 million | $15.53 million | $27.49 million |
| Diluted EPS | $0.15 | $0.22 | $0.46 | $0.81 |
| Net Interest Income | $79.36 million | $83.88 million | $157.32 million | $166.21 million |
| Net Interest Margin (NIM) | 3.56% | 3.83% | 3.54% | 3.86% |
| Provision for Credit Losses | $19.15 million | $29.08 million | $31.55 million | $40.78 million |
| Noninterest Income | $19.42 million | $26.62 million | $33.91 million | $45.96 million |
| Noninterest Expense | $73.30 million | $72.50 million | $139.90 million | $137.23 million |
| Total Assets | $9.75 billion | $9.49 billion (Avg) | $9.75 billion | $9.40 billion (Avg) |
| Total Deposits | $7.82 billion | $7.89 billion (Dec '23) | $7.82 billion | $7.89 billion (Dec '23) |
| Allowance for Credit Losses (ACL) | $94.40 million | $105.96 million (Jun '23) | $94.40 million | $105.96 million (Jun '23) |
| Non-Performing Assets (NPA) | $121.13 million | $54.58 million (Dec '23) | $121.13 million | $54.58 million (Dec '23) |
Material Changes vs. Prior Period
- Profitability Decline: Net income decreased 32.1% year-over-year in Q2 and 43.5% year-over-year for the six months ended June 30, 2024. This was driven by lower net interest income and significantly lower noninterest income, partially offset by a reduced provision for credit losses.
- Net Interest Margin Compression: NIM declined to 3.56% in Q2 2024 from 3.83% in Q2 2023. The decrease was primarily due to higher costs of total deposits (increasing to 2.98% from 2.40%) and FHLB advances, which outpaced the increase in loan yields.
- Noninterest Income Volatility: Noninterest income dropped 27.0% in Q2 2024. The primary driver was the absence of a $13.4 million gain on the early extinguishment of FHLB advances recorded in Q2 2023. Additionally, derivative losses replaced gains seen in the prior year.
- Asset Quality Deterioration: Non-performing assets (NPA) more than doubled to $121.1 million from $54.6 million at year-end 2023. This increase was largely due to the reclassification of loans held for sale related to the Houston transaction and specific downgrades of commercial loans based on updated borrower financials. Non-accrual loans rose to $97.05 million.
- Deposit Mix Shift: Total deposits decreased slightly by 1.0% from year-end 2023. Interest-bearing demand deposits declined significantly, while savings and money market accounts increased.
Guidance, Outlook, and Risks
- Houston Sale Transaction: The Company expects to close the sale of its Houston operations in November 2024. This transaction involves the transfer of approximately $551.8 million in loans and $545.4 million in deposits. The Company recorded $5.5 million in non-routine expenses in Q2 2024 related to this sale, including asset impairments and valuation allowances.
- Capital and Liquidity: The Company remains well-capitalized, with a Common Equity Tier 1 (CET1) ratio of 9.60% and a Tier 1 leverage ratio of 8.74% as of June 30, 2024. Liquidity is supported by $310.3 million in cash and cash equivalents and $2.1 billion in remaining FHLB borrowing capacity.
- Dividends and Buybacks: The Board declared a quarterly dividend of $0.09 per share. The Company continued its stock repurchase program, buying back 200,652 shares in Q2 2024 at a weighted average price of $22.17.
- Risks: Key risks include the potential disruption from the Houston sale, continued pressure on net interest margins due to elevated deposit costs, and credit quality deterioration in the commercial real estate and commercial loan portfolios. The Company also faces risks related to its international exposure, primarily in Venezuela, though these loans are largely collateralized by U.S. assets.
Investor Verification Checklist
- Houston Transaction Closing: Verify the final closing date and any adjustments to the purchase price, specifically regarding the "Deposit Premium" calculation which is subject to deposit balance fluctuations.
- Non-Performing Loan Trends: Monitor the resolution of the $97 million in non-accrual loans, particularly the $47.3 million in newly downgraded commercial loans in Florida, to assess future charge-off risks.
- Deposit Cost Trajectory: Track the cost of deposits, which rose to 2.98% in Q2, to determine if margin compression will persist or if the Company can successfully shift to lower-cost core deposits.
- Provision Adequacy: Review the specific reserves added for non-performing loans ($12.7 million in Q2) against actual charge-offs to evaluate the sufficiency of the $94.4 million ACL.
- Securities Portfolio: Assess the impact of the $108.7 million in net unrealized losses on the available-for-sale securities portfolio on the Company's capital position and potential future realized losses if sales are required.